CalciMedica, Inc. (CALC)
Nasdaq: CALC · Pharmaceutical Preparations · La Jolla, CA · filing with the SEC since 2011
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
| Report filed | Mar 3, 2026 | Mar 27, 2025 | Mar 28, 2024 | Mar 9, 2023 | Mar 11, 2022 | Mar 5, 2021 | · |
| For lenders | |||||||
| Noninterest income | 713 | 1,014 | · | · | · | · | · |
| Research and development | 15,234 | 14,478 | 15,859 | 8,350r | 18,903 | 20,962 | 30,580 |
| General and administrative | 7,887 | 9,726 | 22,216 | 5,843r | 17,044 | 8,870 | 6,922 |
| Total operating expenses | 23,121 | 24,204 | 38,075 | 14,193r | 35,947 | 29,832 | 37,502 |
| Operating income | -23,121 | -24,204 | -38,075 | -14,193r | -35,947 | -29,832 | -37,502 |
| Interest expense | 1,422 | 0 | · | · | · | · | · |
| Interest and investment income | · | · | · | 575 | 126 | 143 | 393 |
| Other income (expense), net | 268 | 0r | 550r | -28 | · | · | · |
| Total non-operating income (expense) | -6,441 | 10,504 | 3,718 | 6,369 | · | · | · |
| Income before income taxes | -29,562 | -13,700 | · | · | · | · | · |
| Income tax expense | 0 | 0 | 1 | 1 | · | · | · |
| Net income including non-controlling interests | -29,562 | -13,700 | -34,357 | -7,824r | -35,821 | -27,531 | -37,037 |
| Net income | -29,562 | -13,700 | -34,357 | -7,824r | -35,821 | -27,531 | -37,037 |
| Preferred dividends | · | · | · | · | · | 7,189 | 7,055 |
| Net income to common shareholders | -29,562 | -13,700 | -34,357 | -9,142 | -35,821 | -34,720 | -44,092 |
| Earnings per share, basic | -1.97 | -1.22 | -7.66 | -111.16r | -1.69 | · | · |
| Earnings per share, diluted | -1.97 | -1.22 | -7.66 | -111.16r | -1.69 | · | · |
| Earnings per share, basic and diluted | · | · | · | · | -1.69 | -5.25 | -33.41 |
| Weighted average shares, basic | 15,011,321 | 11,245,915 | 4,486,258 | 82,245r | 21,199,291 | · | · |
| Weighted average shares, diluted | 15,011,321 | 11,245,915 | 4,486,258 | 82,245r | 21,199,291 | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | 21,199,291 | 6,618,445 | 1,319,912 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Noninterest income fees and other income that is not interest
us-gaap:NoninterestIncomeResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperatingInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossPreferred dividends paid to preferred holders before common shareholders
us-gaap:PreferredStockDividendsIncomeStatementImpactNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted